An affiliate of Peak Rock Capital, a middle-market private investment firm, announce it has signed a definitive agreement for the sale of Paragon Healthcare to Elevance Health. Paragon is a provider of ambulatory and home infusion services as well as specialty pharmacy services. The company provides comprehensive, high quality infusion services to patients with chronic health conditions and those in need of post-acute care. Headquartered in Plano, Texas, with more than 70 infusion and pharmacy locations in 12 states, the company has built an excellent reputation in the industry for its service to patients across lower-cost settings of care, including infusion centers and patients’ homes.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on ELV:
- Elevance Health price target raised to $580 from $560 at Truist
- Elevance, HCSC vying for Cigna’s Medicare Advantage unit, Bloomberg says
- Elevance, HCSC vying for Cigna Medicare Advantage unit, Bloomberg says
- Elevance Health price target lowered by $40 at BofA, here’s why
- Elevance Health price target lowered to $552 from $569 at JPMorgan
